Daily Compliance News: June 9, 2025, The Repugnant Edition
Compliance into the Weeds: Boeing, a NPA and the End of Monitors
Daily Compliance News: May 23, 2025, The Gutless Wonders Edition
Daily Compliance News: March 26, 2025, The Missile Strike on Boeing Edition
FCPA Compliance Report: How Boeing Can Make a Cultural Comeback
Episode 315 - Boeing Pays $51 Million for ITAR Violations
Episode 165 -- Boeing Continues to Suffer from 737 MAX Safety Crisis
Daily Compliance News: October 14, 2020-the More Boeing edition
Episode 143 -- The Boeing Safety Scandal and Corporate Culture
Accountability: At the Heart of Compliance-Boeing, Part 1-Accountability from Employees
Compliance into the Weeds: Episode 120-On the Ethical Tarmac
Compliance into the Weeds: Episode 115-Regulatory Capture and Regulatory Approval at the FAA
I-23- Stunning End-Of-Year NLRB Developments: An Extensive Interview With Former NLRB Associate General Counsel Barry Kearney
The tariff policy implemented by the Trump administration in April 2025 marks a significant shift for the aviation sector by ending long-standing duty-free status in aircraft trading. As a result, U.S. manufacturers and...more
A mounting death toll (over 106 and counting) and fears of a coronavirus pandemic sent markets tumbling early on Monday and kicked off a selloff that continued all day....more
The U.S. and China have tentatively [maybe?] agreed that a first phase of a trade agreement “would roll back a portion of the tariffs placed on each other’s products, a significant step toward defusing tensions between the...more
We didn’t get flop sweat Zuck, but it was still a hot seat indeed for Facebook’s founder and CEO on the Hill yesterday, who fielded a wide range of questions from Libra to political freedom of expression on his platform....more
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....more
The US and China agreed to resume trade talks after a 7-week hiatus, “averting for now an escalation of their multibillion-dollar tariff war that has roiled global markets and threatened the future of the world’s two largest...more